Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function

NCT: NCT07601841 · RECRUITING

NCT IDNCT07601841
StatusRECRUITING
Start Date2025-12-12
Completion2030-09-30

Brief Summary

This is a clinical trial designed to examine how improved sleep through morning bright light therapy is improving downstream key physiologic processes related to brain health, i.e., mitochondrial function, systemic inflammation, and glymphatic function. All proposed methodology is already approved in other IRB applications.

Frequently Asked Questions

What is Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function?

Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function is a clinical trial registered under NCT07601841. Current status: RECRUITING.

What is the status of NCT07601841?

The current status of NCT07601841 (Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function) is: RECRUITING.

When did Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function start?

Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function started on 2025-12-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑